Intel
Since inventing the microprocessor, Intel has been the driving force behind the global technology revolution. Today, Intel innovation is shaping the future with life-enhancing technologies that create new markets, solve real-world problems and inspire the next generation of innovators. Intel believes that young people are the key to solving global challenges, and a solid math and science foundation coupled with skills such as critical thinking, collaboration, and digital literacy are crucial for their success. That is why we get directly involved in education programs, advocacy, and technology access to enable tomorrow's innovators.
Roche Applied Science
Roche Applied Science, a business area of Roche Diagnostics, is a leading producer of reagents and systems for life science research. The company's product portfolio and capabilities in genomics and cell biology, including next-generation sequencing, high density microarrays, real-time PCR and real-time label-free cellular analysis, are enlarging the life science knowledge pool and transforming our understanding of disease.
Tata Consultancy Services
Tata Consultancy Services is an IT services, business solutions and outsourcing organization that delivers real results to global businesses, ensuring a level of certainty no other firm can match. TCS offers a consulting-led, integrated portfolio of IT and IT-enabled services delivered through its unique Global Network Delivery ModelTM , recognized as the benchmark of excellence in software development. A part of the Tata Group, India's largest industrial conglomerate, TCS has over 143,000 of the world's best trained IT consultants in 42 countries. The company generated consolidated revenues of US $6 billion for fiscal year ended 31 March 2009 and is listed on the National Stock Exchange and Bombay Stock Exchange in India.
Alnylam Pharmaceuticals
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is applying its therapeutic expertise in RNAi to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies, the current major classes of drugs. Alnylam is leading the translation of RNAi as a new class of innovative medicines with peer-reviewed research efforts published in the world's top scientific journals including Nature, Nature Medicine, and Cell.
New England Biolabs
Established in mid 1970's, New England Biolabs, Inc. leads the industry in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, cellular analysis, markers and ladders, competent cells and RNA analysis.
